Cohance Lifesciences Limited has informed the Exchange about Resignation of Director/KMP/SMP
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivek Sharma has resigned as Executive Chairman and Director of Cohance Lifesciences Limited, effective April 30, 2026, citing personal reasons. He served during the company's important growth phase and thanked the board, management, employees, and customers. Simultaneously, Umang Vohra has been appointed as the new Executive Chairman effective May 1, 2026. Vohra brings over 30 years of experience, having previously served as Managing Director and Global CEO of Cipla Limited, and CFO at Dr. Reddys Laboratories.
The resignation of the Executive Chairman is a significant leadership change, but the immediate appointment of an experienced external leader like Umang Vohra, who previously led Cipla, provides continuity and may reassure investors about the company's strategic direction.